A Boston federal judge on Monday dropped one of several patent infringement claims brought by Covidien LP in a lawsuit headed to trial later this year against competitor Ethicon Endo-Surgery Inc. over a surgical device.
A Pennsylvania federal judge issued a nationwide injunction Monday blocking Trump administration carveouts to the Affordable Care Act's birth control mandate from taking effect, one day after a court in California blocked the same ACA exemptions in 13 states and the District of Columbia.
A former partner in Haynes and Boone LLP's white collar practice group has returned to the law firm's Dallas office — after a stint as assistant general counsel for a public health care company — where he will co-lead its health care and life sciences group, the firm announced Monday.
A compounding pharmacy and its private equity fund owner blasted the government’s objections to a Florida federal magistrate judge’s recommendation to cut a False Claims Act allegation from litigation over their purported $70 million kickback scheme, arguing Friday that the suit doesn’t show they made false certifications to Tricare.
A group of former Insys Therapeutics Inc. executives charged with bribing doctors to prescribe the company’s opioid spray lit into government lawyers Monday after prosecutors allegedly missed multiple disclosure deadlines, and a Massachusetts federal judge gave the government until midnight to trim its witness and exhibit list.
Amy’s Kitchen Inc. has urged a California federal court to toss a suit from health care giant DaVita Inc. accusing the natural foods company’s employee benefit health plan of effectively removing in-network coverage for dialysis, arguing DaVita had been charging unreasonable prices and its claims lacked any legal basis.
A Boston federal judge ruled Monday that a pediatric heart doctor in Georgia will not go to prison for letting representatives from Aegerion Pharmaceuticals sift through his patients' private information to identify candidates for an expensive medication that was only approved for a condition none of the children had.
A California federal judge late Sunday barred the Trump administration from letting more employers in 13 states and Washington, D.C., invoke religious or moral objections to avoid an Affordable Care Act requirement to provide no-cost birth control to workers.
Law360's top four Firms of the Year notched a combined 32 Practice Group of the Year awards after successfully securing wins in bet-the-company matters and closing high-profile, big-ticket deals for clients throughout 2018.
Law360 congratulates the winners of its 2018 Practice Group of the Year awards, which honor the law firms behind the litigation wins and major deals that resonated throughout the legal industry in the past year.
A D.C. federal judge Friday ripped into the U.S. Department of Justice antitrust attorneys who have been pushing him to approve CVS Health Corp.’s purchase of Aetna Inc. assets after they filed a status report claiming they cannot work on the case until the government shutdown ends.
The last week has seen Axa sue a private health-care provider, AIG take on shipper MSC and an appeal by a printer cartridge maker that has been fighting a multimillion-pound award to its pension trustees.
Excitement for stock sales and acquisitions was somewhat restrained at this year’s JPMorgan’s health care conference, according to several attorneys who attended the event in San Francisco that concluded Thursday, given uncertainties caused by market volatility and the government shutdown.
DLA Piper is bitterly contesting its disqualification as counsel in a $45 million case involving Horizon Blue Cross Blue Shield of New Jersey, arguing that a Florida magistrate judge erred egregiously by treating its role as a go-between for two opposing clients as unethical.
A Texas federal judge refused Thursday to toss a doctor’s $19.2 million antitrust suit accusing Baptist Healthcare System Inc. of excluding him and 70 percent of pediatric anesthesiologists in the San Antonio, Texas, area from working at its hospitals.
The U.S. Department of Justice’s ho-hum performance last year in False Claims Act litigation marked its second straight year of sagging recoveries, sparking questions about whether the DOJ can revive its glory days of blockbuster FCA hauls.
Lewis Brisbois Bisgaard & Smith LLP, Pierce Bainbridge Beck Price & Hecht LLP, McGuireWoods LLP, Bradley Arant Boult Cummings LLP, Dentons and King & Spalding LLP are the latest firms to add new health and life sciences talent to their ranks.
A New Jersey appeals court on Friday affirmed a $100,000 fine regulators imposed on First Jersey Insurance Agency over its advertisements announcing impending Medicare gap coverage hikes, ruling that the mailings violated state insurance laws.
A Ninth Circuit panel on Thursday threw out a putative consumer class action claiming that the labels on Nature’s Bounty Inc. vitamin E supplements falsely advertise health benefits, finding that there was not enough evidence the supplements are “actually harmful, as opposed to simply useless” at promoting immune health.
Teva Pharmaceutical Industries Ltd. will pay $135 million to the state of Illinois to clear up allegations the Israeli drugmaker bilked the government by inflating prices for medicines covered by the state's Medicaid program, according to a settlement announced Thursday.
The 116th Congress has an ideal opportunity to pass bipartisan privacy legislation that could safeguard consumer data, provide clear and uniform rules for businesses, and preserve innovation. Yet any new legislation faces significant hurdles, say Joseph Facciponti and Maxwell Thompson of Murphy & McGonigle PC.
Although the U.S. Environmental Protection Agency's new standards for hazardous waste pharmaceuticals are a major step toward eliminating the current state-by-state regulatory approach, it may not fully end this patchwork system, say Karlie Webb and Greg Blount of Troutman Sanders LLP.
2018 will be remembered as a transition year for technology-assisted review, and 2019 will likely see a continued focus on how we use TAR, with refinement and expansion across the board, says Thomas Gricks of Catalyst Repository Systems LLC.
Following a Texas federal judge's recent opinion that the Affordable Care Act is rendered unconstitutional by the Tax Cuts and Jobs Act of 2017, Andrew Oringer of Dechert LLP reviews some history leading up to the decision and explores how the issues should be analyzed.
Last year saw another round of year-over-year growth in litigation finance, as debates shifted from whether it should be permitted to how it can best be managed. The exciting news, says Alan Guy of Vannin Capital PCC, is that 2019 seems likely to bring more of the same.
Leveraging technology in a fiercely competitive market is a key factor driving law firms toward technology adoption in 2019, as they face growing demand from legal talent and clients for the ability to connect, access and control information whenever and wherever needed, says Tomas Suros of tech provider AbacusNext.
Brutal cybersecurity developments in 2018 demonstrated the premium placed on sound, proactive planning. Companies that establish the capacity to tag and track their data from cradle to grave will find themselves more able to successfully navigate the global regulatory crosscurrents this year, say attorneys with Eversheds Sutherland LLP.
At least 10 bills seeking to liberalize Texas’ marijuana laws have been filed in advance of the state’s 2019 legislative session. Employers rightfully wonder whether any of these potential changes would affect their ability to maintain a drug-free workplace or test for marijuana use, says Steve Roppolo of Fisher Phillips.
Law360 guest authors weighed in on a host of key legal industry issues this year, ranging from in-house tips for success and open secrets about BigLaw diversity to criticisms of the equity partnership and associate salary models. Here are five articles that captured the most attention.
If the federal government shuts down on Friday, the issues contractors face will vary depending on their government counterparts and individual agreements, but all should assess the likely impacts on their operations and make contingency plans, say attorneys at Crowell & Moring LLP.